SCM
TSVT

SCS Capital Management’s 2seventy bio TSVT Stock Holding History

SCS Capital Management’s Portfolio TSVT Stock Details TSVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-41,392
Closed -$204K – 563
2025
Q1 		$204K Buy
+41,392
New +$132K ﹤0.01% 489

Other funds holding TSVT

N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

SCS Capital Management's TSVT Position: Q2 2025 in Review

SCS Capital Management sold out of 2seventy bio (TSVT) in Q2 2025, closing a stake of 41,392 shares — an estimated $204K sold.

SCS Capital Management first reported a position in TSVT in Q1 2025 and held it in 1 quarter. The position peaked at $204K in Q1 2025. 2 funds tracked by Wall St. Rank hold TSVT as of Q2 2025.

  • SCS Capital Management reported no remaining 2seventy bio position as of Q2 2025 after selling out during the quarter.
  • SCS Capital Management sold 41,392 2seventy bio shares in Q2 2025, an estimated $204K.
  • SCS Capital Management first reported a position in 2seventy bio in Q1 2025 and held it in 1 quarter.
  • SCS Capital Management's 2seventy bio position peaked at $204K in Q1 2025.
  • 2 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2025.

Based on SCS Capital Management's 13F filing for Q2 2025, filed 13 Aug 2025.